Circadian Rhythm Sleep Treatment Market by Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Description

The circadian rhythm sleep treatment market is a rapidly evolving sector, driven by increasing awareness about sleep disorders and advancements in sleep medicine. This market encompasses various treatments and therapies designed to address disruptions in the body's internal clock, affecting sleep-wake cycles and overall health. This report delves into the key factors driving growth, potential challenges, and emerging trends in the circadian rhythm sleep treatment market from 2024 through 2031, providing valuable insights for stakeholders and healthcare professionals.

The global circadian rhythm sleep treatment market is expected to experience steady growth during the forecast period, with a projected CAGR of 4.7% from 2024 to 2031. The market is estimated to expand from a value of USD 784 million in 2024 to USD 1.1 billion by the end of 2031.

Key Insights:

Estimated Market Value (2024): USD 784 million
Projected Market Value (2031): USD 1.1 Billion
Global Market Growth Rate (CAGR 2024 to 2031): 4.7%

Circadian Rhythm Sleep Treatment Market - Report Scope:

Circadian rhythm sleep disorders (CRSDs) are becoming more prevalent due to modern lifestyle changes and increased exposure to artificial light, impacting the natural sleep-wake cycle. These disorders include delayed sleep phase disorder (DSPD), advanced sleep phase disorder (ASPD), shift work disorder, and jet lag disorder. The report explores the scope of these treatments, covering various therapies such as light therapy, melatonin supplements, behavioral therapy, and pharmacological approaches.

Market Growth Drivers:

The growth of the circadian rhythm sleep treatment market is driven by several factors. Increasing awareness about the importance of sleep health and its impact on overall well-being is a significant driver. Additionally, the rising prevalence of sleep disorders due to modern lifestyles, stress, and work-related factors fuels the demand for effective treatments. Advances in sleep technology and personalized medicine are enabling more accurate diagnosis and tailored treatment approaches, further boosting market growth. The growing adoption of wearable sleep tracking devices and mobile health applications also contributes to the increased awareness and management of sleep disorders.

Market Restraints:

Despite its growth potential, the circadian rhythm sleep treatment market faces several challenges. High costs associated with some treatments, especially those involving advanced technology or personalized approaches, can deter widespread adoption. Limited access to specialized sleep clinics and professionals in certain regions may also restrict market growth. Additionally, lack of awareness about circadian rhythm disorders among the general population can hinder early diagnosis and treatment. Concerns about the potential side effects of pharmacological treatments and dependency on sleep aids can also affect consumer confidence.

Market Opportunities:

The circadian rhythm sleep treatment market presents numerous opportunities for innovation and expansion. Companies can focus on developing more accessible and affordable treatment options, such as light therapy devices and sleep-tracking wearables. Collaborative efforts between sleep experts and technology companies can lead to more integrated and user-friendly solutions. The rise of telehealth and virtual consultations offers an opportunity to expand access to sleep treatment services, especially in remote areas. Furthermore, increasing public awareness campaigns about sleep health can drive early diagnosis and encourage preventive measures, ultimately contributing to market growth.

Key Questions Addressed in the Report:

What is the Expected Value CAGR of the Circadian Rhythm Sleep Treatment Market?
What is the Revenue Size of the Global Circadian Rhythm Sleep Treatment Market as of 2024-end?
Which Region Held the Largest Market Share in 2024?
Who are the Key Players in the Global Circadian Rhythm Sleep Treatment Market?
What are the Most Effective Treatments for Circadian Rhythm Sleep Disorders?

Competitive Landscape and Business Strategies:

The competitive landscape in the circadian rhythm sleep treatment market features a mix of established pharmaceutical companies and innovative tech startups. Key players like Jazz Pharmaceuticals, Philips Healthcare, and Fitbit offer a range of sleep treatment solutions, from pharmacological therapies to wearable devices. Jazz Pharmaceuticals focuses on developing medications for sleep disorders, including narcolepsy and insomnia. Philips Healthcare offers a variety of sleep-related devices, such as light therapy and continuous positive airway pressure (CPAP) machines. Fitbit, a leader in wearable technology, has integrated sleep tracking features into its fitness devices, enabling users to monitor and improve their sleep patterns.

Key Companies Profiled:

Jazz Pharmaceuticals
Philips Healthcare
Fitbit
ResMed
Takeda Pharmaceuticals
Vanda Pharmaceuticals
Garmin
Zeo Health
Beddit
Casio Computer Co., Ltd.
Medtronic

Circadian Rhythm Sleep Treatment Market Segmentation:

By Treatment Type:

Light Therapy
Melatonin Supplements
Behavioral Therapy
Pharmacological Treatment

By Distribution Channel:

Hospitals and Sleep Clinics
Online Retail
Specialty Pharmacies

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Product Code: PMRREP27310

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Disorder Roadmap Analysis
1.5. Analysis and Recommendations

2. Market Introduction

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Global Circadian Rhythm Sleep Treatment Market Key Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation Trends
3.3. Innovations & New Launches
3.4. Disease Overview and Epidemiology (Prevalence Data), by Region

4. Global Circadian Rhythm Sleep Treatment Market Key Success Factors

4.1. Product Adoption / Awareness Analysis
4.2. Product Features Vs. Disorder Matrix

5. Global Circadian Rhythm Sleep Treatment Market - Pricing Analysis

5.1. Regional Pricing Analysis
5.2. Pricing Break-Up
- 5.2.1. Manufacturer Level Pricing
- 5.2.2. Distributor Level Pricing
5.3. Global Average Pricing Analysis Benchmark

6. Global Circadian Rhythm Sleep Treatment Market Demand Analysis 2019-2023 and Forecast, 2024-2031

6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
6.3. Y-o-Y Growth Trend Analysis

7. Global Circadian Rhythm Sleep Treatment Market Context

7.1. Key Regulations
7.2. Macro-Economic Factors
7.3. Forecast Factors - Relevance & Impact
7.4. Market Dynamics
- 7.4.1. Drivers
- 7.4.2. Restraints
- 7.4.3. Opportunity Analysis

8. Global Circadian Rhythm Sleep Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Treatment Type

8.1. Introduction/Key Finding
- 8.1.1. Market Size (US$ Mn) and Volume Share Analysis By Treatment Type
- 8.1.2. Y-o-Y Growth Analysis By Treatment Type
8.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Treatment Type, 2019-2023
8.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Treatment Type, 2024-2031
- 8.3.1. Devices
  - 8.3.1.1. Therapeutic Devices
    - 8.3.1.1.1. Light Box
    - 8.3.1.1.2. Desk Lamps
    - 8.3.1.1.3. Light Visor
    - 8.3.1.1.4. Dawn Simulator
  - 8.3.1.2. Diagnostic Devices
    - 8.3.1.2.1. Actigraphy Sensors
    - 8.3.1.2.1.1. Wrist and Hand band Actigraphy Devices
    - 8.3.1.2.1.2. Wearable Actigraphy Devices
    - 8.3.1.2.2. Polysomnography Devices
    - 8.3.1.2.2.1. Fixed Polysomnography Devices
    - 8.3.1.2.2.2. Portable Polysomnography Devices
- 8.3.2. Drugs
  - 8.3.2.1. Benzodiazepines
  - 8.3.2.2. Nonbenzodiazepine hypnotics
  - 8.3.2.3. Orexin receptor antagonists
  - 8.3.2.4. Melatonin receptor agonist
- 8.3.3. Chronotherapy
8.4. Market Attractiveness Analysis By Treatment Type

9. Global Circadian Rhythm Sleep Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Disorder

9.1. Introduction/Key Finding
- 9.1.1. Market Size (US$ Mn) Analysis By Disorder
- 9.1.2. Y-o-Y Growth Analysis By Disorder
9.2. Historical Market Size (US$ Mn) Analysis By Disorder , 2019-2023
9.3. Market Size (US$ Mn) Forecast By Disorder , 2024-2031
- 9.3.1. Delayed Sleep Phase Syndrome (DSPS)
- 9.3.2. Advanced Sleep Phase Syndrome (ASPS)
- 9.3.3. Non-24-h Sleep-Wake Syndrome
- 9.3.4. Irregular Sleep-Wake Disorder (ISWD)
- 9.3.5. Shift Work Disorder
- 9.3.6. Jet Lag
9.4. Market Attractiveness Analysis By Disorder

10. Global Circadian Rhythm Sleep Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Distribution Channel

10.1. Introduction/Key Finding
- 10.1.1. Market Size (US$ Mn) Analysis By Distribution Channel
- 10.1.2. Y-o-Y Growth Analysis By Distribution Channel
10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2019-2023
10.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2024-2031
- 10.3.1. Institutional Sales
  - 10.3.1.1. Home Care Settings
  - 10.3.1.2. Wellness Centers & Spa
  - 10.3.1.3. Sleep Testing Centers
  - 10.3.1.4. Specialty Clinics
  - 10.3.1.5. Hospitals
- 10.3.2. Retail Sales
  - 10.3.2.1. Retail Pharmacies
  - 10.3.2.2. Drug Stores
  - 10.3.2.3. Online Sales
10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Circadian Rhythm Sleep Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Region

11.1. Introduction/Key Finding
- 11.1.1. Market Size (US$ Mn) and Volume Share Analysis By Region
- 11.1.2. Y-o-Y Growth Analysis By Region
11.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Region, 2019-2023
11.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Region, 2024-2031
- 11.3.1. North America
- 11.3.2. Latin America
- 11.3.3. Europe
- 11.3.4. South Asia
- 11.3.5. East Asia
- 11.3.6. Oceania
- 11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region

12. North America Circadian Rhythm Sleep Treatment Market Analysis 2019-2023 and Forecast 2024-2031

12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2019-2023
12.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2024-2031
- 12.3.1. By Country
  - 12.3.1.1. U.S.
  - 12.3.1.2. Canada
- 12.3.2. By Treatment Type
- 12.3.3. By Disorder
- 12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Treatment Type
- 12.4.3. By Disorder
- 12.4.4. By Distribution Channel
12.5. Drivers and Restraints: Impact Analysis
12.6. Key Market Participants - Intensity Mapping

13. Latin America Circadian Rhythm Sleep Treatment Market Analysis 2019-2023 and Forecast 2024-2031

13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2019-2023
13.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2024-2031
- 13.3.1. By Country
  - 13.3.1.1. Brazil
  - 13.3.1.2. Mexico
  - 13.3.1.3. Argentina
  - 13.3.1.4. Rest of Latin America
- 13.3.2. By Treatment Type
- 13.3.3. By Disorder
- 13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Treatment Type
- 13.4.3. By Disorder
- 13.4.4. By Distribution Channel
13.5. Drivers and Restraints: Impact Analysis
13.6. Key Market Participants - Intensity Mapping

14. Europe Circadian Rhythm Sleep Treatment Market Analysis 2019-2023 and Forecast 2024-2031

14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2019-2023
14.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2024-2031
- 14.3.1. By Country
  - 14.3.1.1. U.K.
  - 14.3.1.2. Germany
  - 14.3.1.3. France
  - 14.3.1.4. Italy
  - 14.3.1.5. Spain
  - 14.3.1.6. BENELUX
  - 14.3.1.7. Nordic
  - 14.3.1.8. Poland
  - 14.3.1.9. Rest of Europe
- 14.3.2. By Treatment Type
- 14.3.3. By Disorder
- 14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Treatment Type
- 14.4.3. By Disorder
- 14.4.4. By Distribution Channel
14.5. Drivers and Restraints: Impact Analysis
14.6. Key Market Participants - Intensity Mapping

15. East-Asia Circadian Rhythm Sleep Treatment Market Analysis 2019-2023 and Forecast 2024-2031

15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2019-2023
15.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2024-2031
- 15.3.1. By Country
  - 15.3.1.1. China
  - 15.3.1.2. Japan
  - 15.3.1.3. South Korea
  - 15.3.1.4. Rest of East Asia
- 15.3.2. By Treatment Type
- 15.3.3. By Disorder
- 15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Treatment Type
- 15.4.3. By Disorder
- 15.4.4. By Distribution Channel
15.5. Drivers and Restraints: Impact Analysis
15.6. Key Market Participants - Intensity Mapping

16. South Asia Circadian Rhythm Sleep Treatment Market Analysis and Forecast 2019-2023 and Forecast 2024-2031

16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2019-2023
16.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2024-2031
- 16.3.1. By Country
  - 16.3.1.1. India
  - 16.3.1.2. Thailand
  - 16.3.1.3. Malaysia
  - 16.3.1.4. Indonesia
  - 16.3.1.5. Philippines
  - 16.3.1.6. Rest of South Asia
- 16.3.2. By Treatment Type
- 16.3.3. By Disorder
- 16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Treatment Type
- 16.4.3. By Disorder
- 16.4.4. By Distribution Channel
16.5. Drivers and Restraints: Impact Analysis
16.6. Key Market Participants - Intensity Mapping

17. Oceania Circadian Rhythm Sleep Treatment Market Analysis and Forecast 2019-2023 and Forecast 2024-2031

17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2019-2023
17.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2024-2031
- 17.3.1. By Country
  - 17.3.1.1. Australia
  - 17.3.1.2. New Zealand
- 17.3.2. By Treatment Type
- 17.3.3. By Disorder
- 17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Treatment Type
- 17.4.3. By Disorder
- 17.4.4. By Distribution Channel
17.5. Drivers and Restraints: Impact Analysis
17.6. Key Market Participants - Intensity Mapping

18. MEA Circadian Rhythm Sleep Treatment Market Analysis and Forecast 2019-2023 and Forecast 2024-2031

18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2019-2023
18.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2024-2031
- 18.3.1. By Country
  - 18.3.1.1. GCC Countries
  - 18.3.1.2. Iran
  - 18.3.1.3. Israel
  - 18.3.1.4. Turkey
  - 18.3.1.5. Rest of MEA
- 18.3.2. By Treatment Type
- 18.3.3. By Disorder
- 18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Treatment Type
- 18.4.3. By Disorder
- 18.4.4. By Distribution Channel
18.5. Drivers and Restraints: Impact Analysis
18.6. Key Market Participants - Intensity Mapping

19. Competition Analysis

19.1. Competition Dashboard
19.2. Pricing Analysis, By Competition
19.3. Competition Benchmarking
19.4. Gross Margin Analysis, By Competition
19.5. Competition Developments
19.6. Competition Deep Dive
- 19.6.1. Vanda Pharmaceuticals Inc.
  - 19.6.1.1. Overview
  - 19.6.1.2. Product and Disorder Portfolio
  - 19.6.1.3. Production Footprint
  - 19.6.1.4. Sales Footprint
  - 19.6.1.5. Strategy
    - 19.6.1.5.1. Marketing Strategy
    - 19.6.1.5.2. Product Strategy
    - 19.6.1.5.3. Channel Strategy
- 19.6.2. Natus Medical Incorporated
  - 19.6.2.1. Overview
  - 19.6.2.2. Product and Disorder Portfolio
  - 19.6.2.3. Production Footprint
  - 19.6.2.4. Sales Footprint
  - 19.6.2.5. Strategy
    - 19.6.2.5.1. Marketing Strategy
    - 19.6.2.5.2. Product Strategy
    - 19.6.2.5.3. Channel Strategy
- 19.6.3. Compumedics Ltd.
  - 19.6.3.1. Overview
  - 19.6.3.2. Product and Disorder Portfolio
  - 19.6.3.3. Production Footprint
  - 19.6.3.4. Sales Footprint
  - 19.6.3.5. Strategy
    - 19.6.3.5.1. Marketing Strategy
    - 19.6.3.5.2. Product Strategy
    - 19.6.3.5.3. Channel Strategy
- 19.6.4. Teva Pharmaceutical Industries Ltd
  - 19.6.4.1. Overview
  - 19.6.4.2. Product and Disorder Portfolio
  - 19.6.4.3. Production Footprint
  - 19.6.4.4. Sales Footprint
  - 19.6.4.5. Strategy
    - 19.6.4.5.1. Marketing Strategy
    - 19.6.4.5.2. Product Strategy
    - 19.6.4.5.3. Channel Strategy
- 19.6.5. Takeda Pharmaceutical Company
  - 19.6.5.1. Overview
  - 19.6.5.2. Product and Disorder Portfolio
  - 19.6.5.3. Production Footprint
  - 19.6.5.4. Sales Footprint
  - 19.6.5.5. Strategy
    - 19.6.5.5.1. Marketing Strategy
    - 19.6.5.5.2. Product Strategy
    - 19.6.5.5.3. Channel Strategy
- 19.6.6. Koninklijke Philips N.V
  - 19.6.6.1. Overview
  - 19.6.6.2. Product and Disorder Portfolio
  - 19.6.6.3. Production Footprint
  - 19.6.6.4. Sales Footprint
  - 19.6.6.5. Strategy
    - 19.6.6.5.1. Marketing Strategy
    - 19.6.6.5.2. Product Strategy
    - 19.6.6.5.3. Channel Strategy
- 19.6.7. Mylan N.V
  - 19.6.7.1. Overview
  - 19.6.7.2. Product and Disorder Portfolio
  - 19.6.7.3. Production Footprint
  - 19.6.7.4. Sales Footprint
  - 19.6.7.5. Strategy
    - 19.6.7.5.1. Marketing Strategy
    - 19.6.7.5.2. Product Strategy
    - 19.6.7.5.3. Channel Strategy
- 19.6.8. Fitbit, Inc
  - 19.6.8.1. Overview
  - 19.6.8.2. Product and Disorder Portfolio
  - 19.6.8.3. Production Footprint
  - 19.6.8.4. Sales Footprint
  - 19.6.8.5. Strategy
    - 19.6.8.5.1. Marketing Strategy
    - 19.6.8.5.2. Product Strategy
    - 19.6.8.5.3. Channel Strategy
- 19.6.9. Garmin Ltd
  - 19.6.9.1. Overview
  - 19.6.9.2. Product and Disorder Portfolio
  - 19.6.9.3. Production Footprint
  - 19.6.9.4. Sales Footprint
  - 19.6.9.5. Strategy
    - 19.6.9.5.1. Marketing Strategy
    - 19.6.9.5.2. Product Strategy
    - 19.6.9.5.3. Channel Strategy
- 19.6.10. Lucimed S.A.
  - 19.6.10.1. Overview
  - 19.6.10.2. Product and Disorder Portfolio
  - 19.6.10.3. Production Footprint
  - 19.6.10.4. Sales Footprint
  - 19.6.10.5. Strategy
    - 19.6.10.5.1. Marketing Strategy
    - 19.6.10.5.2. Product Strategy
    - 19.6.10.5.3. Channel Strategy
- 19.6.11. RedMed Inc.
  - 19.6.11.1. Overview
  - 19.6.11.2. Product and Disorder Portfolio
  - 19.6.11.3. Production Footprint
  - 19.6.11.4. Sales Footprint
  - 19.6.11.5. Strategy
    - 19.6.11.5.1. Marketing Strategy
    - 19.6.11.5.2. Product Strategy
    - 19.6.11.5.3. Channel Strategy
- 19.6.12. Compass Health Brands (Carex Health)
  - 19.6.12.1. Overview
  - 19.6.12.2. Product and Disorder Portfolio
  - 19.6.12.3. Production Footprint
  - 19.6.12.4. Sales Footprint
  - 19.6.12.5. Strategy
    - 19.6.12.5.1. Marketing Strategy
    - 19.6.12.5.2. Product Strategy
    - 19.6.12.5.3. Channel Strategy
- 19.6.13. Beurer GmbH
  - 19.6.13.1. Overview
  - 19.6.13.2. Product and Disorder Portfolio
  - 19.6.13.3. Production Footprint
  - 19.6.13.4. Sales Footprint
  - 19.6.13.5. Strategy
    - 19.6.13.5.1. Marketing Strategy
    - 19.6.13.5.2. Product Strategy
    - 19.6.13.5.3. Channel Strategy
- 19.6.14. Samarit Medical AG
  - 19.6.14.1. Overview
  - 19.6.14.2. Product and Disorder Portfolio
  - 19.6.14.3. Production Footprint
  - 19.6.14.4. Sales Footprint
  - 19.6.14.5. Strategy
    - 19.6.14.5.1. Marketing Strategy
    - 19.6.14.5.2. Product Strategy
    - 19.6.14.5.3. Channel Strategy
- 19.6.15. Lanaform N.V.
  - 19.6.15.1. Overview
  - 19.6.15.2. Product and Disorder Portfolio
  - 19.6.15.3. Production Footprint
  - 19.6.15.4. Sales Footprint
  - 19.6.15.5. Strategy
    - 19.6.15.5.1. Marketing Strategy
    - 19.6.15.5.2. Product Strategy
    - 19.6.15.5.3. Channel Strategy